LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

By |2021-06-22T09:13:46+00:00June 22nd, 2021|News|

Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up… Continue Reading LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Read Article
Comments Off on LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

EU Logo
Northern Powerhouse Logo
NE LEP
Newcastle Council Logo
Newcastle Helix Logo

The Biosphere is part of the Newcastle Helix community.

It is part funded by the England European
Regional Development fund as part of the European Structural And Investment Funds Growth Programme 2014-2020 and the North East Local Growth Fund from HM Government, Administered by the North East Local Enterprise Partnership.

Get in touch
Request a callback
Skip to content
This Website is committed to ensuring digital accessibility for people with disabilitiesWe are continually improving the user experience for everyone, and applying the relevant accessibility standards.
Conformance status
Developed by AGHAI Web Development
Go to Top